| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. | Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Titapun, A. Koonmee, S. Loilome, W. |
2017 | ||||
| 2. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 | ||||
| 3. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 | ||||
| 4. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 | ||||
| 5. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 | ||||
| 6. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. | Phetcharaburanin, J Deewai, S Kulthawatsiri, T Moolpia, K Suksawat, M Promraksa, B Klanrit, P Namwat, N Loilome, W Poopasit, K Katekaew, S Phetcharaburanin, P |
2020 | ||||
| 7. | H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Jutarop Phetcharaburanin Suthicha Deewai Thanaporn Kulthawatsiri Komkid Moolpia Manida Suksawat Bundit Promraksa Poramate Klanrit Nisana Namwat Watcharin Loilome Kitisak Poopasit Somporn Katekaew Penprapa Phetcharaburanin |
2020 | ||||
| 8. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines | Dokduang, H Jamnongkarn, W Promraksa, B Suksawat, M Padthaisong, S Thanee, M Phetcharaburanin, J Namwat, N Sangkhamanon, S Titapun, A Khuntikeo, N Klanrit, P Loilome, W |
2020 | ||||
| 9. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Phetcharaburanin, J. Moolpia, K. Suksawat, M. Promraksa, B. Klanrit, P. Namwat, N. Loilome, W. Poopasit, K. Katekaew, S. Phetcharaburanin, P. |
2020 | ||||
| 10. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. | Phuc N. Ho Poramate Klanrit Yupa Hanboonsong Umaporn Yordpratum Manida Suksawat Thanaporn Kulthawatsiri Anyarin Jirahiranpat Suthicha Deewai Panya Mackawan Rasana W. Sermswan Nisana Namwat Watcharin Loilome Tueanjit Khampitak Arporn Wangwiwatsin Jutarop Phetcharaburanin |
2021 | ||||
| 11. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 | ||||
| 12. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 | ||||
| 13. | Spirogyra neglecta (Hassall) Kützing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway | Phetcharaburanin, J. | 2021 | ||||
| 14. | Spirogyra neglecta (Hassall) Kueurotzing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway | Punnida Arjsri Jutarop Phetcharaburanin Manida Suksawat Sariya Mapoung Chayaporn Subkamkaew Warathit Semmarath Supachai Yodkeeree Pornngarm Limtrakul Dejkriengkraikul |
2021 | ||||
| 15. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 | ||||
| 16. | Therapeutic challenges at the preclinical level for targeted drug development for -associated cholangiocarcinoma. | Loilome, W Dokduang, H Suksawat, M Padthaisong, S |
2021 | ||||
| 17. | Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma | Watcharin Loilome Hasaya Dokduang Manida Suksawat Sureerat Padthaisong |
2021 | ||||
| 18. | 1H NMR metabolic profiling of Staphylococcus pseudintermedius isolated from canine uroliths. | Uttamamul, N Suksawat, M Phetcharaburanin, J Jitpean, S Lulitanond, A Sae-Ung, N Boonsiri, P Tavichakorntrakool, R |
2022 | ||||
| 19. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 | ||||
| 20. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 | ||||
| 21. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 | ||||
| 22. | FAME4-associating YEATS2 knockdown impairs dopaminergic synaptic integrity and leads to seizure-like behaviours in Drosophila melanogaster. | Piccolo, LL Yeewa, R Pohsa, S Yamsri, T Calovi, D Phetcharaburanin, J Suksawat, M Kulthawatsiri, T Shotelersuk, V Jantrapirom, S |
2023 | ||||
| 23. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 | ||||
| 24. | Physiological traits and metabolic profiles of contrasting rice cultivars under mild salinity stress during the seedling stage | Jumpa, T. Phetcharaburanin, J. Suksawat, M. Pattanagul, W. |
2023 | ||||
| 25. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 | ||||
| 26. | Metabolic profiles and some physiological traits of three rice cultivars differing in salinity tolerance under salinity stress at the germination stage | Jumpa, T. Phetcharaburanin, J. Suksawat, M. Pattanagul, K. Pattanagul, W. |
2024 | ||||
| 27. | Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Sa-Ngiamwibool, P Panwoon, C Loilome, W Klanrit, P Techasen, A Chamgramol, Y Suksawat, M Armartmuntree, N O'Connor, T Saya, H Thanee, M |
2025 | ||||
| 28. | NMR-based metabolomics of biofilms and extracellular polymeric substance cultured in LB and MVBM media. | Srithabut, S Chareonsudjai, P Chaianunporn, T Bunma, C Phetcharaburanin, J Suksawat, M Chitcharoen, S Chareonsudjai, S |
2025 | ||||
| 29. | Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Kaewlert, W Techasen, A Loilome, W Klanrit, P Suksawat, M Chaleekan, K Sitthirak, S Thanee, M |
2025 | Count | 15 | 19 | 11 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Titapun, A. Koonmee, S. Loilome, W. |
2017 |
Parasitology International 4 (66), pp. 486-493 |
||||||||
| 2. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 |
FEBS Open Bio 4 (8), pp. 513-522 |
||||||||
| 3. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
| 4. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 |
Drug Design, Development and Therapy (14), pp. 2319-2334 |
||||||||
| 5. | <sup>1</sup>H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Phetcharaburanin, J. Moolpia, K. Suksawat, M. Promraksa, B. Klanrit, P. Namwat, N. Loilome, W. Poopasit, K. Katekaew, S. Phetcharaburanin, P. |
2020 |
PLoS ONE 12 December (15), pp. |
||||||||
| 6. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Klanrit, P. Hanboonsong, Y. Yordpratum, U. Suksawat, M. Sermswan, R.W. Namwat, N. Loilome, W. Khampitak, T. Wangwiwatsin, A. Phetcharaburanin, J. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 7. | High levels of serum igg for opisthorchis viverrini and cd44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 |
International Journal of General Medicine (14), pp. 2191-2204 |
||||||||
| 8. | Spirogyra neglecta (Hassall) Kützing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway | Phetcharaburanin, J. | 2021 |
South African Journal of Botany (139), pp. 26-37 |
||||||||
| 9. | Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma | Loilome, W. Dokduang, H. Suksawat, M. Padthaisong, S. |
2021 |
Expert Opinion on Investigational Drugs 9 (30), pp. 985-1006 |
||||||||
| 10. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 11. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 12. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 13. | Physiological traits and metabolic profiles of contrasting rice cultivars under mild salinity stress during the seedling stage | Jumpa, T. Phetcharaburanin, J. Suksawat, M. Pattanagul, W. |
2023 |
Notulae Botanicae Horti Agrobotanici Cluj-Napoca 2 (51), pp. |
||||||||
| 14. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 15. | Metabolic profiles and some physiological traits of three rice cultivars differing in salinity tolerance under salinity stress at the germination stage | Jumpa, T. Phetcharaburanin, J. Suksawat, M. Pattanagul, K. Pattanagul, W. |
2024 |
Asian Journal of Agriculture and Biology 1 (2024), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. | Suksawat, M Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Koonmee, S Loilome, W |
2017 |
Parasitology international 4 (66), pp. 486-493 |
|
| 2. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 |
FEBS open bio 4 (8), pp. 513-522 |
|
| 3. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 |
PloS one 9 (14), pp. e0222140 |
|
| 4. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. | Phetcharaburanin, J Deewai, S Kulthawatsiri, T Moolpia, K Suksawat, M Promraksa, B Klanrit, P Namwat, N Loilome, W Poopasit, K Katekaew, S Phetcharaburanin, P |
2020 |
PloS one 12 (15), pp. e0243432 |
|
| 5. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Dokduang, H Jamnongkarn, W Promraksa, B Suksawat, M Padthaisong, S Thanee, M Phetcharaburanin, J Namwat, N Sangkhamanon, S Titapun, A Khuntikeo, N Klanrit, P Loilome, W |
2020 |
Drug design, development and therapy (14), pp. 2319-2334 |
|
| 6. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 |
International journal of general medicine (14), pp. 2191-2204 |
|
| 7. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 11 |
|
| 8. | Therapeutic challenges at the preclinical level for targeted drug development for -associated cholangiocarcinoma. | Loilome, W Dokduang, H Suksawat, M Padthaisong, S |
2021 |
Expert opinion on investigational drugs (), pp. 1-22 |
|
| 9. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. | Ho, PN Klanrit, P Hanboonsong, Y Yordpratum, U Suksawat, M Kulthawatsiri, T Jirahiranpat, A Deewai, S Mackawan, P Sermswan, RW Namwat, N Loilome, W Khampitak, T Wangwiwatsin, A Phetcharaburanin, J |
2021 |
Scientific reports 1 (11), pp. 23316 |
|
| 10. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 |
Frontiers in public health (10), pp. 766023 |
|
| 11. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 |
PeerJ (10), pp. e13876 |
|
| 12. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 |
Frontiers in pharmacology (13), pp. 897368 |
|
| 13. | 1H NMR metabolic profiling of Staphylococcus pseudintermedius isolated from canine uroliths. | Uttamamul, N Suksawat, M Phetcharaburanin, J Jitpean, S Lulitanond, A Sae-Ung, N Boonsiri, P Tavichakorntrakool, R |
2022 |
PloS one 11 (17), pp. e0277808 |
|
| 14. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 |
Scientific reports 1 (13), pp. 3072 |
|
| 15. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 |
PeerJ (11), pp. e15386 |
|
| 16. | FAME4-associating YEATS2 knockdown impairs dopaminergic synaptic integrity and leads to seizure-like behaviours in Drosophila melanogaster. | Piccolo, LL Yeewa, R Pohsa, S Yamsri, T Calovi, D Phetcharaburanin, J Suksawat, M Kulthawatsiri, T Shotelersuk, V Jantrapirom, S |
2023 |
Progress in neurobiology (), pp. 102558 |
|
| 17. | Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Sa-Ngiamwibool, P Panwoon, C Loilome, W Klanrit, P Techasen, A Chamgramol, Y Suksawat, M Armartmuntree, N O'Connor, T Saya, H Thanee, M |
2025 |
Scientific reports 1 (15), pp. 11984 |
|
| 18. | NMR-based metabolomics of biofilms and extracellular polymeric substance cultured in LB and MVBM media. | Srithabut, S Chareonsudjai, P Chaianunporn, T Bunma, C Phetcharaburanin, J Suksawat, M Chitcharoen, S Chareonsudjai, S |
2025 |
Biofouling (), pp. 1-14 |
|
| 19. | Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Kaewlert, W Techasen, A Loilome, W Klanrit, P Suksawat, M Chaleekan, K Sitthirak, S Thanee, M |
2025 |
Scientific reports 1 (15), pp. 20420 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Manida Suksawat Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Supinda Koonmee Watcharin Loilome |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 486.0-493.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 2. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Manida Suksawat Anchalee Techasen Nisana Namwat Thianrut Boonsong Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Watcharin Loilome |
2018 |
FEBS OPEN BIO 4.0 (8.0), pp. 513.0-522.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 3. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 746.0-746.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Manida Suksawat Poramate Klanrit Jutarop Phetcharaburanin Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Prakasit Sa-ngiamwibool Anchalee Techasen Watcharin Loilome |
2019 |
PLOS ONE 9.0 (14.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 5. | H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Jutarop Phetcharaburanin Suthicha Deewai Thanaporn Kulthawatsiri Komkid Moolpia Manida Suksawat Bundit Promraksa Poramate Klanrit Nisana Namwat Watcharin Loilome Kitisak Poopasit Somporn Katekaew Penprapa Phetcharaburanin |
2020 |
PLOS ONE 12.0 (15.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 |
DRUG DESIGN DEVELOPMENT AND THERAPY (14.0), pp. 2319.0-2334.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 7. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Phuc N. Ho Poramate Klanrit Yupa Hanboonsong Umaporn Yordpratum Manida Suksawat Thanaporn Kulthawatsiri Anyarin Jirahiranpat Suthicha Deewai Panya Mackawan Rasana W. Sermswan Nisana Namwat Watcharin Loilome Tueanjit Khampitak Arporn Wangwiwatsin Jutarop Phetcharaburanin |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 8. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (14.0), pp. 2191.0-2204.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | Spirogyra neglecta (Hassall) Kueurotzing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway | Punnida Arjsri Jutarop Phetcharaburanin Manida Suksawat Sariya Mapoung Chayaporn Subkamkaew Warathit Semmarath Supachai Yodkeeree Pornngarm Limtrakul Dejkriengkraikul |
2021 |
SOUTH AFRICAN JOURNAL OF BOTANY (139.0), pp. 26.0-37.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 10. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 11. | Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma | Watcharin Loilome Hasaya Dokduang Manida Suksawat Sureerat Padthaisong |
2021 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS 9.0 (30.0), pp. 985.0-1006.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|